Diagnostic News and Research

RSS

Researchers explore effects of attention bias modification in adolescents with MDD

A study to be published in the March 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents with major depression who performed a computer-based task designed to shift attention from sad to neutral to positive word associations showed reductions in negative attention biases and clinician-rated depressive symptoms.

25 Feb 2016

New computer program and electronic stethoscope developed to diagnose lung problems

The classic stethoscope has entered the digital age. Medical researchers have created a computer program that connects to an electronic stethoscope to classify lung sounds into five common diagnostic categories.

24 Feb 2016

New BayCare Cardiovascular and Thoracic Surgery office opens at St. Anthony's Hospital

To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.

24 Feb 2016

Texas Children's Hospital, Houston Methodist Hospital jointly release country's first rapid test for Zika virus

Collaboration between two Texas Medical Center institutions has resulted in today's release of the country's first hospital-based rapid tests for the Zika virus.

23 Feb 2016

Hiroshima University researchers identify new class of cancer-causing genetic variations

Researchers at Hiroshima University have opened the door to finding a new class of cancer-causing genetic variations.

23 Feb 2016

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.

23 Feb 2016

EPFL researchers develop portable microfluidic diagnostic device to detect different diseases

When remote regions with limited health facilities experience an epidemic, they need portable diagnostic equipment that functions outside the hospital. As demand for such equipment grows, EPFL researchers have developed a low-cost and portable microfluidic diagnostic device. It has been tested on Ebola and can be used to detect many other diseases.

22 Feb 2016

Newly developed intravital microscopy system proves safe for use in humans

A team of Roswell Park Cancer Institute researchers has developed and evaluated the first intravital microscopy system shown to be safe for use in humans. Writing in the journal Nature Communications, the scientists report that their proprietary technology enabled them, for the first time ever, to visualize tumor blood vessels in real time.

22 Feb 2016

Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy designation to PKC412 (midostaurin). PKC412 (midostaurin) is an investigational treatment for adults with newly-diagnosed AML who are FLT3 mutation-positive, as detected by an FDA-approved test, and who are eligible to receive standard induction and consolidation chemotherapy.

19 Feb 2016

Commonly used chemo toxins damage eyesight in childhood cancer survivors

A study from Lund University in Sweden shows that commonly used chemo toxins impair the eyesight in childhood cancer survivors in a way that indicates an impact on the central nervous system.

18 Feb 2016

FDA issues new guidance to reduce risk of Zika blood transmission

As a safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.

18 Feb 2016

Autoantibodies can potentially detect lung cancer at early stage

Preliminary research has identified autoantibodies, immune proteins found in the blood specific for one's own proteins, that can potentially detect lung cancer early by distinguishing between smokers with or without lung cancer and also discriminate between lung cancer and low-dose computed tomography (LDCT) detected non-cancerous lung lesions.

18 Feb 2016

FUJIFILM Medical Systems receives FDA clearance for Synapse 5

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, announced it has received FDA 510 (k) clearance for the sale and distribution of its most recent innovation in PACS technology, Synapse 5.

18 Feb 2016

Penn researchers use network science to gain new insights into torn ligament

When doctors diagnose a torn ligament, it's usually because they can see ruptures in the ligament's collagen fibers, visible on a variety of different scans. However, they also often treat patients with many of the symptoms of a tear, but whose ligaments don't show this kind of damage.

17 Feb 2016

Atlas io system allows infectious diseases to be detected in less than 30 minutes

University of Bath spin-out biotechnology company Atlas Genetics has won approval from the EU to sell a device that detects the sexually transmitted disease chlamydia.

17 Feb 2016

CTCA hosts second ‘Annual New Treatments in Oncology’ conference

Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.

17 Feb 2016

Aytu BioScience announces business strategy update and Q2 financial results

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, provided today an overview of its business and growth strategy, as well as its financial results for the quarter ended December 31, 2015.

17 Feb 2016

Apogenix awarded €3 million grant to develop immuno-oncology candidate APG101 as personalized therapy

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it has received funding approval in the amount of €3 million from the German Federal Ministry of Education and Research for the so-called CancerMark project.

16 Feb 2016

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.

16 Feb 2016

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.

16 Feb 2016

Diagnostic News and Research

Researchers explore effects of attention bias modification in adolescents with MDD

New computer program and electronic stethoscope developed to diagnose lung problems

New BayCare Cardiovascular and Thoracic Surgery office opens at St. Anthony's Hospital

Texas Children's Hospital, Houston Methodist Hospital jointly release country's first rapid test for Zika virus

Hiroshima University researchers identify new class of cancer-causing genetic variations

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

EPFL researchers develop portable microfluidic diagnostic device to detect different diseases

Newly developed intravital microscopy system proves safe for use in humans

Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)

Commonly used chemo toxins damage eyesight in childhood cancer survivors

FDA issues new guidance to reduce risk of Zika blood transmission

Autoantibodies can potentially detect lung cancer at early stage

FUJIFILM Medical Systems receives FDA clearance for Synapse 5

Penn researchers use network science to gain new insights into torn ligament

Atlas io system allows infectious diseases to be detected in less than 30 minutes

CTCA hosts second ‘Annual New Treatments in Oncology’ conference

Aytu BioScience announces business strategy update and Q2 financial results

Apogenix awarded €3 million grant to develop immuno-oncology candidate APG101 as personalized therapy

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News